跳至主要内容
临床试验/NCT05836545
NCT05836545已完成3 期

A Randomized, Single-Blind, Investigator Initiative Trial Study of Remimazolam Versus Midazolam for Sedation in Diagnostic Upper Gastrointestinal Endoscopy

Samsung Medical Center1 个研究点 分布在 1 个国家目标入组 132 人开始时间: 2023年4月5日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
132
试验地点
1
主要终点
Total procedure time

研究概览

简要总结

The goal of this clinical trial is to compare the efficacy of remimazolam with midazolam in patients undergoing gastrointestinal endoscopy. The main questions it aims to answer are:

  • Superiority of total procedure time in remimazolam compared to midazolam
  • The success of sedation time

This is the single blind study.; Patients will not know what they are given as the sedation drug If there is a comparison group: Researchers will compare patients with midazolam group to see if remimazolam group is superior to midazolam group

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who agreed for this clinical trials
  • Patients who want diagnostic endoscopy under sedation
  • The total procedure time which is predicted within 15 minutes
  • BMI more than 18.5kg/m2, less than 30kg/m2

排除标准

  • Patients who have stomach illness
  • Patients with respiratory disease
  • Mallampati Score>=3
  • Systolic BP >160mmHg or <90mmHg
  • Refractory Hypertension
  • Uncontrolled glaucoma
  • Severe liver failure or chronic kidney disease
  • Patients with drug abuse or alcohol abuse within 1 year
  • Patients who are sensitive for certain medication (such as benzodiazepine, remimazolam)
  • Obstructive sleep dyspnea patients
  • Galactose intolerance, Lapp lactase deficiency, glucose-galactose malabsorption
  • Pregnant, breast feeding patient

研究组 & 干预措施

Midazolam

Active Comparator

The patient with midazolam

干预措施: Midazolam (Drug)

Remimazolam

Experimental

The patient with remimazolam

干预措施: Remimazolam (Drug)

结局指标

主要结局

Total procedure time

时间窗: begin when the drug is give to when the endoscopy is withdrawn

次要结局

  • The success rate of sedation(Completion of the whole endoscopy procedures, No requirement for an alternative and/or rescue sedative, Administered up to a maximum of five supplemental doses within 15 mnutes after the initial dose)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Remimazolam Versus Midaszolam for Sedation in... | 临床试验